Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 06 May 2024 10:28 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 04/2024 | 20103015 Pharmaceuticals | Corporate life |
| 24 Apr 2024 18:00 CEST |
VIRBAC | Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format) | 20103015 Pharmaceuticals | Other subject |
| 24 Apr 2024 18:00 CEST |
VIRBAC | Virbac : Communiqué de mise à disposition du Rapport Annuel au format ESEF au 31 décembre 2023 | 20103015 Pharmaceuticals | Other subject |
| 16 Apr 2024 17:45 CEST |
VIRBAC | VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates | 20103015 Pharmaceuticals | Sales |
| 16 Apr 2024 17:45 CEST |
VIRBAC | VIRBAC: sur la lancée du second semestre 2023, forte croissance du chiffre d’affaires sur le premier trimestre de +10,8% à taux de change constants | 20103015 Pharmaceuticals | Sales |
| 09 Apr 2024 14:46 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 03/2024 | 20103015 Pharmaceuticals | Corporate life |
| 09 Apr 2024 14:46 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 03/2024 | 20103015 Pharmaceuticals | Corporate life |
| 02 Apr 2024 17:45 CEST |
VIRBAC | Virbac acquired Sasaeah, a leading animal health player in Japan | 20103015 Pharmaceuticals | Mergers, Acquisitions, Transfers |
| 02 Apr 2024 17:45 CEST |
VIRBAC | Virbac acquiert Sasaeah, un acteur majeur de la santé animale au Japon | 20103015 Pharmaceuticals | Mergers, Acquisitions, Transfers |
| 19 Mar 2024 18:00 CET |
VIRBAC | Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023 | 20103015 Pharmaceuticals | Income |
| 19 Mar 2024 18:00 CET |
VIRBAC | Virbac: Communiqué de mise à disposition des comptes consolidés au 31 décembre 2023 | 20103015 Pharmaceuticals | Income |
| 19 Mar 2024 17:45 CET |
VIRBAC | VIRBAC: 2023 ANNUAL RESULTS | 20103015 Pharmaceuticals | Sales |
| 19 Mar 2024 17:45 CET |
VIRBAC | Virbac : Résultats annuels 2023 | 20103015 Pharmaceuticals | Sales |
| 11 Mar 2024 11:03 CET |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 02/2024 | 20103015 Pharmaceuticals | Corporate life |
| 11 Mar 2024 11:03 CET |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 02/2024 | 20103015 Pharmaceuticals | Corporate life |
| 06 Mar 2024 08:20 CET |
VIRBAC | Virbac to take a leading position in Japan through the acquisition of Sasaeah | 20103015 Pharmaceuticals | Mergers, Acquisitions, Transfers |
| 06 Mar 2024 08:20 CET |
VIRBAC | Virbac prend une position de leader au Japon grâce à l'acquisition de Sasaeah | 20103015 Pharmaceuticals | Mergers, Acquisitions, Transfers |
| 06 Feb 2024 15:54 CET |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 01/2024 | 20103015 Pharmaceuticals | Corporate life |
| 06 Feb 2024 15:54 CET |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 01/2024 | 20103015 Pharmaceuticals | Corporate life |
| 17 Jan 2024 17:45 CET |
VIRBAC | VIRBAC: Annual revenue growth of +4.9% thanks to record fourth-quarter activity at +11.5% | 20103015 Pharmaceuticals | Sales |
| 17 Jan 2024 17:45 CET |
VIRBAC | VIRBAC: Croissance du chiffre d’affaires annuel à +4,9% grâce à un niveau record d’activité au quatrième trimestre à +11,5% | 20103015 Pharmaceuticals | Sales |
| 08 Jan 2024 11:09 CET |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 12/2023 | 20103015 Pharmaceuticals | Corporate life |
| 08 Jan 2024 11:09 CET |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 12/2023 | 20103015 Pharmaceuticals | Corporate life |
| 19 Dec 2023 08:30 CET |
VIRBAC | Outlook 2023-2024 | 20103015 Pharmaceuticals | Other subject |
| 19 Dec 2023 08:30 CET |
VIRBAC | Perspectives 2023-2024 | 20103015 Pharmaceuticals | Other subject |
| 07 Dec 2023 12:10 CET |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 11/2023 | 20103015 Pharmaceuticals | Corporate life |
| 07 Dec 2023 12:10 CET |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 11/2023 | 20103015 Pharmaceuticals | Corporate life |
| 09 Nov 2023 12:11 CET |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 10/2023 | 20103015 Pharmaceuticals | Corporate life |
| 09 Nov 2023 12:11 CET |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 10/2023 | 20103015 Pharmaceuticals | Corporate life |
| 06 Nov 2023 15:43 CET |
VIRBAC | MAR Weekly Report_VIRBAC SA_October 30 to November 3 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 06 Nov 2023 15:43 CET |
VIRBAC | MAR Rapport Hebdomadaire_VIRBAC SA_30 octobre au 3 novembre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 02 Nov 2023 17:45 CET |
VIRBAC | VIRBAC: Virbac acquired a majority stake in Globion, a leading Indian poultry vaccines specialist | 20103015 Pharmaceuticals | Mergers, Acquisitions, Transfers |
| 02 Nov 2023 17:45 CET |
VIRBAC | VIRBAC: Virbac acquiert une participation majoritaire de Globion, un spécialiste indien des vaccins volaille | 20103015 Pharmaceuticals | Mergers, Acquisitions, Transfers |
| 30 Oct 2023 14:06 CET |
VIRBAC | MAR Weekly Repport_VIRBAC SA_23 to 27 October 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 30 Oct 2023 14:06 CET |
VIRBAC | MAR Rapport Hebdomadaire_VIRBAC SA_23 au 27 octobre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 23 Oct 2023 17:45 CEST |
VIRBAC | VIRBAC: revenue growth at the end of September at +2.8% at constant exchange rates and scope thanks to a strong activity rebound in the third quarter (+7.8% at constant exchange rates and scope) | 20103015 Pharmaceuticals | Sales |
| 23 Oct 2023 17:45 CEST |
VIRBAC | VIRBAC: croissance du chiffre d’affaires à fin septembre à +2,8% à taux de change et périmètre constants grâce à un fort rebond de l’activité au troisième trimestre (+7,8% à taux de change et périmètre constants) | 20103015 Pharmaceuticals | Sales |
| 23 Oct 2023 11:23 CEST |
VIRBAC | MAR Weekly Report_VIRBAC SA_16 to 20 October 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 23 Oct 2023 11:23 CEST |
VIRBAC | MAR Rapport Hebdomadaire_VIRBAC SA_16 au 20 octobre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 16 Oct 2023 11:24 CEST |
VIRBAC | VIRBAC: MAR Weekly Report_VIRBAC SA_9 to 13 October 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 16 Oct 2023 11:24 CEST |
VIRBAC | VIRBAC: MAR Rapport Hebdomadaire_VIRBAC SA_9 au 13 octobre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 16 Oct 2023 09:57 CEST |
VIRBAC | Virbac : Declaration of the number of shares and voting rights 0/2023 | 20103015 Pharmaceuticals | Corporate life |
| 16 Oct 2023 09:57 CEST |
VIRBAC | Virbac : Déclaration d'actions et de droits de vote 09/2023 | 20103015 Pharmaceuticals | Corporate life |
| 09 Oct 2023 13:18 CEST |
VIRBAC | Virbac will enter the fast-growing poultry vaccines segment in India | 20103015 Pharmaceuticals | Alliances and agreements |
| 09 Oct 2023 13:18 CEST |
VIRBAC | Virbac va pénétrer le segment à forte croissance des vaccins pour volaille en Inde | 20103015 Pharmaceuticals | Alliances and agreements |
| 09 Oct 2023 09:55 CEST |
VIRBAC | VIRBAC: MAR Weekly Report_VIRBAC SA_2 to 6 October 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 09 Oct 2023 09:55 CEST |
VIRBAC | VIRBAC: MAR Rapport Hebdomadaire_VIRBAC SA_2 au 6 octobre 2023 | 20103015 Pharmaceuticals | Share introduction and issues |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Half-yearly financial report 2023 | 20103015 Pharmaceuticals | - |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Rapport financier semestriel 2023 | 20103015 Pharmaceuticals | - |
| 06 Oct 2023 18:00 CEST |
VIRBAC | Virbac : Public release of the Half-Year Financial Report at 30 June 2023. | 20103015 Pharmaceuticals | Other subject |